Mumbai, Nov 24: Dabur India has acquired a 72.15 per cent stake in skincare entity Fem Care Pharma (FCPL) for Rs 203.7 crore.
The acquisition was approved by Dabur's board of directors on ascribed price per share of Rs 800, with equity valuation of Rs 282.4 crore and an enterprise valuation of approximately Rs 300 crore of Fem Care Pharma Ltd, announced a company release here on Monday, Nov 24. Dabur will also make an open offer for an additional 20 per cent shares of Fem Care as per takeover regulations. ''The acquisition of Fem Care Pharma is in line with our strategy to aggressively expand Dabur's scale of operations and strengthen its presence in the consumer goods (FMCG) space,'' said Dr Anand Burman, chairman of Dabur India.
He said the transaction would give Dabur an entry into the high-growth skin care market with an established brand name and the potential to extend the brand into newer and related skincare categories.